Validation of a New Standardized Clinical Anemia Evaluation Score Using a Hb Visual Scale in Nephrological Patients

This study has been completed.
Sponsor:
Information provided by:
University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:
NCT00478582
First received: May 24, 2007
Last updated: January 12, 2011
Last verified: January 2011
  Purpose

The clinical evaluation of anemia is usually done by examination of the palpebral conjontivae coloration. This appreciation remains crude and largely observer dependent, as no reference scale was successfully proposed,. A Hb visual scale allowing the assessment of the degree of clinical anemia has been developed. Its use has been validated so far in small patient groups in the following settings: blood donation, cardiac surgery, oncology and consultation of general practitioners.

The objective of the present investigation is to validate the use of a Hb visual scale for the clinical evaluation of anemia in patients with kidney disease patients


Condition Intervention
Anemia
Procedure: Estimation of Hb concentrations with the HemoHue card

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Double-Blind
Primary Purpose: Diagnostic
Official Title: Validation of a New Standardized Clinical Anemia Evaluation Score Using a Hb Visual Scale in Nephrological Patients

Resource links provided by NLM:


Further study details as provided by University Hospital Inselspital, Berne:

Primary Outcome Measures:
  • Comparison of visual estimated Hb concentrations with measured Hb concentrations

Study Start Date: May 2007
Study Completion Date: December 2007
Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with chronich kidney disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00478582

Locations
Switzerland
Department of nephrology and hypertension, University hospital of berne
Berne, Switzerland, 3010
Sponsors and Collaborators
University Hospital Inselspital, Berne
Investigators
Study Director: Dominik Uehlinger, Prof
Principal Investigator: Dominik Uelinger, Prof
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00478582     History of Changes
Other Study ID Numbers: HB 5/2007
Study First Received: May 24, 2007
Last Updated: January 12, 2011
Health Authority: Switzerland:Cantonal ethic commitee of Berne

Keywords provided by University Hospital Inselspital, Berne:
Anemia
Visual scale
nephrological patients
Anemia in nephrological patients

Additional relevant MeSH terms:
Anemia
Hematologic Diseases

ClinicalTrials.gov processed this record on October 20, 2014